SARS-Cov gene vaccine based on epi-position and its contruction
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- FUDAN UNIV
- Publication Date
- 2005-08-24
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the fields of bioengineering and immunology, and relates to a genetic vaccine. Further, the invention relates to an epitope-based SARS-Cov genetic vaccine constructed by means of genetic engineering. Background technique
[0002] A newly isolated coronavirus (SARS-Cov) is currently recognized as the causative agent of the outbreak of atypical pneumonia. It poses a huge threat to human health and causes huge losses to the economy of our country. It has infected more than 8,000 people on five continents and caused a mortality rate greater than 10%. According to the results of genome sequencing analysis, it is currently known that the main structural proteins of the virus include Spike (S), M and E proteins on the membrane surface, and the N protein connected to the RNA genome, which may become the main target for the development of vaccines. As an infectious disease caused by a virus, vaccines are widely considered to be the mos...